Search Results

Dr. George Named Coprincipal Investigator for Direct Flow's US SALUS Trial

June 4, 2015—Direct Flow Medical, Inc. announced that Isaac George, MD, has been named coprincipal investigator of the United States SALUS pivotal trial. SALUS is a prospective, randomized, multicenter, core-lab adjudicated, United States clinical trial that is evaluating the Direct Flow Medical transcatheter aortic valve replacement (TAVR) system.

Trisol Begins Early Feasibility Study of Transcatheter Tricuspid Valve in the United States

August 29, 2023—Trisol Medical Ltd., which is based in Yokneam, Israel, recently announced the first two implantations in the United States of the Trisol transcatheter tricuspid valve replacement device as part of an FDA-approved early feasibility study (EFS), which is led by Principal Investigator Isaac George, MD.

Foldax Tria Mitral Valve Evaluated in Clinical Trial

June 27, 2025—Foldax Inc., a Utah-based developer of polymer heart valves, announced 1-year results from a clinical trial in India of the company’s Tria mitral valve.

EnCompass F2 Cerebral Embolic Filter for TAVR Used in First Procedures

June 2, 2023—EnCompass Technologies, Inc. recently announced the first use of its novel F2 cerebral embolic filter.

Foldax Tria Mitral Valve Launched in India

September 5, 2025—Foldax Inc., in conjunction with its local India-based manufacturing partner Dolphin Life Science LLP, announced the launch of the Tria polymer mitral valve in India.

Modifications Strengthen SALUS Pivotal Trial of Direct Flow Medical's TAVR System

April 28, 2016—Direct Flow Medical, Inc. announced modifications to the SALUS United States pivotal trial of the company's transcatheter aortic valve replacement (TAVR) system to include best practices and clinical comparison with all currently available United States TAVR devices.

Valcare Medical Forms Scientific Advisory Board of Mitral Valve Experts

July 2, 2024—Valcare Medical, Inc., a developer of transcatheter-based mitral solutions based in Israel and Florida, announced the formation of a scientific advisory board composed of mitral valve experts.